KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aterian (ATER) Research & Development (2018 - 2023)

Historic Research & Development for Aterian (ATER) over the last 6 years, with Q4 2023 value amounting to $808000.0.

  • Aterian's Research & Development fell 4349.65% to $808000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was $808000.0, marking a year-over-year decrease of 8457.43%. This contributed to the annual value of $4.6 million for FY2023, which is 2322.02% down from last year.
  • According to the latest figures from Q4 2023, Aterian's Research & Development is $808000.0, which was down 4349.65% from $852000.0 recorded in Q3 2023.
  • In the past 5 years, Aterian's Research & Development registered a high of $3.3 million during Q2 2019, and its lowest value of $808000.0 during Q4 2023.
  • Over the past 5 years, Aterian's median Research & Development value was $1.8 million (recorded in 2020), while the average stood at $2.0 million.
  • Per our database at Business Quant, Aterian's Research & Development skyrocketed by 30835.44% in 2019 and then crashed by 5005.86% in 2023.
  • Over the past 5 years, Aterian's Research & Development (Quarter) stood at $2.9 million in 2019, then plummeted by 47.03% to $1.6 million in 2020, then surged by 68.62% to $2.6 million in 2021, then tumbled by 45.36% to $1.4 million in 2022, then tumbled by 43.5% to $808000.0 in 2023.
  • Its Research & Development stands at $808000.0 for Q4 2023, versus $852000.0 for Q3 2023 and $1.7 million for Q2 2023.